Company intelligence / Profile preview

Norstella

Ownership: Private
Development stage: Commercial

Overview

Norstella unites leading pharmaceutical solutions providers—Citeline, Evaluate, MMIT, Panalgo, The Dedham Group—to deliver integrated real-world data analytics, forecasting tools, market access insights, and strategic consulting. Its platforms help biopharma companies accelerate drug development cycles from pipeline to patient by improving decision-making with comprehensive clinical trial intelligence and commercial strategy support. In October 2024 it launched NorstellaLinQ—a fully integrated dataset combining real-world evidence with proprietary business intelligence—enabling faster insights across the entire product lifecycle.

Industry: Biomedical IT and Biomedical Data Platforms

Beyond the preview

Go deeper on Norstella.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Norstella.

Explore the full profile